Williams Jones & Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
BG
Williams Jones & Associates's AGN Position: Q4 2018 in Review
Williams Jones & Associates sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 6,942 shares — an estimated $1.32M sold.
Williams Jones & Associates first reported a position in AGN in Q1 2014 and held it in 18 quarters. The position peaked at $75.5M in Q2 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.
- Williams Jones & Associates reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
- Williams Jones & Associates sold 6,942 Allergan plc shares in Q4 2018, an estimated $1.32M.
- Williams Jones & Associates first reported a position in Allergan plc in Q1 2014 and held it in 18 quarters.
- Williams Jones & Associates's Allergan plc position peaked at $75.5M in Q2 2015.
- 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.
Based on Williams Jones & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.